ISIN | CH0357518890 |
---|---|
Valor Number | 35751889 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund Switzerland Total (II) DT CHF |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The investment objective of the fund is to replicate the performance of the Swiss Performance Index (SPI®). The Swiss Performance Index (SPI®) is constituted from the Swiss Exchange (SIX Swiss Exchange) and tracks the performance of Swiss companies listed on the SIX Swiss Exchange. The fund can deviate from the index.The fund assets are invested as a majority in shares and other equity securities and participation rights. |
Peculiarities |
Current Price * | 154.61 CHF | 20.05.2025 |
---|---|---|
Previous Price * | 153.97 CHF | 19.05.2025 |
52 Week High * | 157.52 CHF | 03.03.2025 |
52 Week Low * | 132.56 CHF | 09.04.2025 |
NAV * | 154.61 CHF | 20.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 5,089,910,111 | |
Unit/Share Assets *** | 22,399,117 | |
Trading Information SIX |
YTD Performance | +10.04% |
31.12.2024 - 20.05.2025
31.12.2024 20.05.2025 |
---|---|---|
1 month | +7.90% |
22.04.2025 - 20.05.2025
22.04.2025 20.05.2025 |
3 months | +0.21% |
20.02.2025 - 20.05.2025
20.02.2025 20.05.2025 |
6 months | +10.71% |
20.11.2024 - 20.05.2025
20.11.2024 20.05.2025 |
1 year | +6.34% |
21.05.2024 - 20.05.2025
21.05.2024 20.05.2025 |
2 years | +11.51% |
22.05.2023 - 20.05.2025
22.05.2023 20.05.2025 |
3 years | +16.72% |
20.05.2022 - 20.05.2025
20.05.2022 20.05.2025 |
5 years | +38.40% |
20.05.2020 - 20.05.2025
20.05.2020 20.05.2025 |
Equity Participation Rate in % | 98.79 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 14.44% | |
---|---|---|
Roche Holding AG | 11.88% | |
Novartis AG Registered Shares | 11.61% | |
Zurich Insurance Group AG | 5.35% | |
UBS Group AG | 4.97% | |
Compagnie Financiere Richemont SA Class A | 4.91% | |
ABB Ltd | 4.33% | |
Holcim Ltd | 3.11% | |
Swiss Re AG | 2.73% | |
Lonza Group Ltd | 2.67% | |
Last data update | 30.04.2025 |
TER | 0.16% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.35% |
Ongoing Charges *** | 0.16% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |